APC2 p.Ala461Val
c.1382C>T · rs758805322 · VCV1360121
Computational evidence
| Protein change | ||
| AlphaMissense | 0.8069 | likely pathogenic |
|---|---|---|
| REVEL | 0.538 | indeterminate |
| SaProt | LLR -9.26 | tolerated |
| ⇒ AlphaMissense calls this damaging; SaProt does not; REVEL is indeterminate. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 7.6 | GERP 1.7, phastCons 1 |
| Overall | ||
| CADD | 29.3 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| Admixed Americangrpmax | 0.015% | 6,668 |
| Remaining individualsnot grpmax-eligible | 0.0048% | 20,827 |
| African / African-American | 0.004% | 24,981 |
| European (non-Finnish) | 0.000508% | 196,671 |
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- APC2
- Protein
- p.Ala461Val
- Coding
- c.1382C>T
- MANE Select
- NM_005883
- dbSNP
- rs758805322
- Type
- single nucleotide variant
- Location
- chr19:1460259 (GRCh38)
- Gene constraint
- LOEUF 0.961 · pLI <0.01 (gnomAD)
- Structure
- AlphaFold pLDDT 48.87
- Residue 461
- a UniProt-annotated variant site (in cdcbm10)
Similar variants
- APC2 p.Ala1059Glu Uncertain significance ★★ ⚠ same condition
- APC2 p.Ala1103Thr Uncertain significance ★★ ⚠ same condition
- APC2 p.Ala1116Val Uncertain significance ★★ ⚠ same condition
- APC2 p.Ala126Ser Uncertain significance ★★ ⚠ same condition
- APC2 p.Ala1311Thr Uncertain significance ★★ ⚠ same condition
- APC2 p.Ala1359Val Uncertain significance ★★ ⚠ same condition
- APC2 p.Ala1438Thr Uncertain significance ★★ ⚠ same condition
- APC2 p.Ala1492Glu Uncertain significance ★★ ⚠ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/apc2-p-ala461val (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown